Back to Journals » OncoTargets and Therapy » Volume 11
Original Research
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,103 | Dovepress* | 8,443+ | 851 | 9,294 | |
PubMed Central* | 660 | 229 | 889 | ||
Totals | 9,103 | 1,080 | 10,183 | ||
*Since 30 November 2018 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
4 | 0 | 0 | 0 | 1 | 3 |
View citations on PubMed Central and Google Scholar